Recombinant Human IGF-1 (Insulin-Like Growth Factor) Therapy: Where Do We Stand Today?

被引：9
作者：
Balhara, Bharti [1 ,2 ]
Misra, Madhusmita [1 ,2 ]
Levitsky, Lynne L. [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp Children, Pediat Endocrine Unit, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02114 USA
来源：
INDIAN JOURNAL OF PEDIATRICS | 2012年 / 79卷 / 02期
关键词：
Recombinant human insulin like growth factor (rhIGF-1); Recombinant human growth hormone (rhGH); Insulin like growth factor binding protein-3 (IGFBP-3); Short stature; HORMONE INSENSITIVITY SYNDROME; FACTOR BINDING-PROTEINS; LONG-TERM TREATMENT; FACTOR-I PRODUCTION; CLINICAL ENDOCRINOLOGY; FACTOR (IGF)-I; CHILDREN; DEFICIENCY; GENERATION; ACID;
D O I：
10.1007/s12098-011-0608-5
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Recombinant human (rh) IGF-1 has been available for therapy since the 1980s and has been commercially available for over 5 y, yet the role of rhIGF-1 in treating children with short stature remains ambiguous. This is consequent to the inherent difficulty in defining criteria for IGF-1 deficiency, and in determining the outcome of rhIGF-1 therapy in terms of growth rate and adult height. The rationale for its efficacy compared with rhGH (recombinant human growth hormone) for treatment of short stature is still widely debated. Additionally, adverse events such as increased intracranial pressure and hypoglycemia are of therapeutic concern. The goal of this article is to review published data that describes the impact of IGF-1 therapy in treatment of short stature and other growth disorders.
引用
收藏
页码：244 / 249
页数：6
相关论文
共 43 条
[1]   Treatment of insulin-like growth factor deficiency with IGF-I: Studies in humans [J].
Backeljauw, PF ;
Chernausek, SD .
HORMONE RESEARCH, 2006, 65 :21-27
[2]   INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEINS IN THE HUMAN CIRCULATION - A REVIEW [J].
BAXTER, RC .
HORMONE RESEARCH, 1994, 42 (4-5) :140-144
[3]   IMPROVEMENT OF DIAGNOSTIC-CRITERIA IN GROWTH-HORMONE INSENSITIVITY SYNDROME - SOLUTIONS AND PITFALLS [J].
BLUM, WF ;
COTTERILL, AM ;
POSTELVINAY, MC ;
RANKE, MB ;
SAVAGE, MO ;
WILTON, P ;
BOULTON, J ;
BRAMSWIG, J ;
CARUSO, M ;
CHATELAIN, P ;
CHAUSSAIN, J ;
DESPERT, F ;
FRASER, N ;
FRISCH, H ;
HEINRICH, C ;
HEINRICH, U ;
HERREREAJUSTINIANO, E ;
HOPP, M ;
KASTRUP, K ;
KRIZISNIK, C ;
LOCHE, S ;
MILNER, D ;
PINTOR, C ;
PRICE, A ;
RANKE, M ;
RAPPAPORT, R ;
ROCHICCIOLI, P ;
DESANCTIS, C ;
SAVAGE, M ;
SKAKKEBAEK, N ;
TRAUBER, M ;
WERTHER, G ;
YOULTON, R .
ACTA PAEDIATRICA, 1994, 83 :117-124
[4]   Insulin-like growth factor binding protein-3 generation as a measure of GH sensitivity [J].
Buckway, CK ;
Selva, KA ;
Pratt, KL ;
Tjoeng, E ;
Guevara-Aguirre, J ;
Rosenfeld, RG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (10) :4754-4765
[5]   The IGF-I generation test revisited: A marker of GH sensitivity [J].
Buckway, CK ;
Guevara-Aguirre, J ;
Pratt, KL ;
Burren, CP ;
Rosenfeld, RG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (11) :5176-5183
[6]  
Camacho-Hubner C, 2006, 88 ANN M END SOC BOS, P40
[7]   Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity [J].
Chernausek, Steven D. ;
Backeljauw, Philippe F. ;
Frane, James ;
Kuntze, Joyce ;
Underwood, Louis E. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (03) :902-910
[8]   Controversy in clinical endocrinology - Problems with reclassification of insulin-like growth factor I production and action disorders [J].
Cohen, Pinchas .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) :4235-4236
[9]   The role of recombinant human insulin-like growth factor-I in treating children with short stature [J].
Collett-Solberg, Paulo F. ;
Misra, Madhusmita .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (01) :10-18
[10]   The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action [J].
CollettSolberg, PF ;
Cohen, P .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1996, 25 (03) :591-&
12345